Tolterodine Immediate Release Improves Sexual Function in Women with Overactive Bladder

Abstract

Introduction Quality of life studies indicate that overactive bladder (OAB) has a greater negative impact on everyday life than other serious conditions such as diabetes. The detrimental effect of OAB on female sexual health is more prominent than urinary incontinence. We know that tolterodine immediate release (IR) has a beneficial effect on urinary symptoms in OAB. Aim To evaluate the impact of tolterodine IR on sexual function in patients with OAB. Methods A total of 30 sexually active women with OAB from 20 to 52 years were included. All patients filled out the International Consultation on Incontinence Questionnaire (ICIQ) and the Arizona Sexual Experience Scale (ASEX) before treatment with tolterodine IR and at the end of each month of treatment until 3 months. Main Outcome Measures Expected outcomes were improvements in the ICIQ and ASEX total score. All ASEX items were expected to improve individually. These improvements indicate better sexual function after treatment. Results The mean of the total ASEX score improved relative to baseline in the first (P < 0.01), second (P < 0.01), and third (P < 0.01) follow-up. The mean of scores for sexual desire, arousal, vaginal lubrication, orgasm, and orgasm satisfaction improved significantly (P < 0.01) with each follow-up. Conclusion Tolterodine IR significantly improves sexual function of women with OAB. Improvement is seen in all domains of sexual function.

OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results

“…Information was collected regarding age, MS symptom onset, comorbidities and concomitant medications, as well as history of depression and, if present, how it had been treated. The diagnosis of MS had been made according to the modified McDonald criteria [7]. All the patients displayed periventricular, juxtacortical, infratentorial and spinal lesions at the magnetic resonance imaging (MRI) scans.…”

The Impact of Urinary Incontinence and Its Treatment on Female Sexual Function

“…Two studies have looked at the impact of tolterodine on sexual function in women with OAB. Rogers et al [32] in 2009 and Hajebrahimi et al [33] in 2008 both found tolterodine to significantly improve sexual function of women with OAB.…”

Stress urinary incontinence and LUTS in women—effects on sexual function

“…55 In the same way, tolterodine immediate release (an antimuscarinic drug that acts on M2 and M3 muscarinic receptors) has been shown to significantly improve sexual function of women with OAB in a prospective cohort study of 30 patients. 56 In a study by Salonia et al, 57 46% of a cohort of 216 women with incontinence, recurrent or persistent LUTS or both reported a sexual function disorder, including hypoactive sexual desire (34%), sexual arousal disorder (23%), orgasmic deficiency (11%) and sexual pain disorder (dyspareunia or noncoital genital pain; 44%). Of the patients with sexual pain disorders, 61% also complained of recurrent bacterial cystitis.…”